Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $6.40 and last traded at $6.28, with a volume of 3703682 shares. The stock had previously closed at $5.04.
Wall Street Analysts Forecast Growth
Separately, Needham & Company LLC increased their target price on Curaleaf from $4.25 to $5.25 and gave the company a "buy" rating in a research note on Thursday, March 7th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Curaleaf currently has an average rating of "Hold" and an average price target of $4.13.
Check Out Our Latest Stock Analysis on CURLF
Curaleaf Stock Performance
The company has a current ratio of 0.85, a quick ratio of 0.41 and a debt-to-equity ratio of 0.87. The stock has a fifty day moving average price of $4.97 and a 200-day moving average price of $4.40. The firm has a market capitalization of $4.05 billion, a price-to-earnings ratio of -16.10 and a beta of 1.77.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings results on Wednesday, March 6th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.04. Curaleaf had a negative return on equity of 12.93% and a negative net margin of 20.77%. The firm had revenue of $345.27 million during the quarter, compared to analysts' expectations of $336.64 million. As a group, analysts anticipate that Curaleaf Holdings, Inc. will post -0.18 earnings per share for the current fiscal year.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
